UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors

Clinical cancer research, 2018-01, Vol.24 (1), p.43-51

2018

Volltextzugriff (PDF)

Challenges in the development of an autologous heat shock protein based anti-tumor vaccine

Human vaccines & immunotherapeutics, 2012-08, Vol.8 (8), p.1152-1155

2012

Volltextzugriff (PDF)

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma a randomized, double-blind, multicenter, comparative trial

Cancer, 2003-10, Vol.98 (8), p.1735-1744

2003

Volltextzugriff (PDF)

Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial

Journal of clinical oncology, 1999-03, Vol.17 (3), p.846-854

1999

Volltextzugriff (PDF)

Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases

The New England journal of medicine, 1996-12, Vol.335 (24), p.1785-1792

1996

Volltextzugriff (PDF)

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

The New England journal of medicine, 1996-02, Vol.334 (8), p.488-493

1996

Volltextzugriff (PDF)

Alternative statistical strategies for biosimilar drug development

GaBI Journal, 2014-03, Vol.3 (1), p.13-20

2014

Volltextzugriff (PDF)

Managing combination immunotherapy trials from a contract research organization's (CRO's) perspective

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.19-19

2019

Volltextzugriff (PDF)

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases long term follow-up of two randomized, placebo-controlled trials

Cancer, 2000-03, Vol.88 (5), p.1082-1090

2000

Volltextzugriff (PDF)

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial

The cancer journal (Sudbury, Mass.), 2001-09, Vol.7 (5), p.377

2001

Volltextzugriff (PDF)

Adult participation in oncology clinical trials by indication, race, and age

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e17586-e17586

2013

Volltextzugriff (PDF)

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2038-2044

1998

Volltextzugriff (PDF)

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events

Journal of clinical oncology, 1998-02, Vol.16 (2), p.593-602

1998

Volltextzugriff (PDF)

Highlighting the challenge of delayed overall survival (OS) curve separation in immunotherapy clinical trials

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3009-3009

2013

Volltextzugriff (PDF)

HER2+ gastric cancer patient demographics and implications for clinical trial enrollment

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e12526-e12526

2014

Volltextzugriff (PDF)

Uptake of BRAF and ALK mutation screening versus HER2 overexpression testing

Journal of clinical oncology, 2012-10, Vol.30 (30_suppl), p.101-101

2012

Volltextzugriff (PDF)

Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma

Cancer, 2003-01, Vol.98 (8), p.1735-1744

2003

Volltextzugriff (PDF)

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases

Cancer, 2000-03, Vol.88 (5), p.1082-1090

2000

Volltextzugriff (PDF)

Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories

The Lancet (British edition), 2018-11, Vol.392 (10159), p.2052-2090

2018

Volltextzugriff (PDF)

Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade

PloS one, 2011-08, Vol.6 (8), p.e23411-e23411

2011

Volltextzugriff (PDF)

Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology

Journal of allergy and clinical immunology, 2019-03, Vol.143 (3), p.1207-1214

2019

Volltextzugriff (PDF)

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Journal of clinical oncology, 2003-08, Vol.21 (16), p.3150-3157

2003

Volltextzugriff (PDF)

Antecolic Versus Retrocolic Route of the Gastroenteric Anastomosis After Pancreatoduodenectomy: A Randomized Controlled Trial

Annals of surgery, 2014-01, Vol.259 (1), p.45-51

2014

Volltextzugriff (PDF)

Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial

JAMA : the journal of the American Medical Association, 2007-08, Vol.298 (8), p.865

2007

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(41)

Sprache

Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors

Challenges in the development of an autologous heat shock protein based anti-tumor vaccine

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma a randomized, double-blind, multicenter, comparative trial

Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial

Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

Alternative statistical strategies for biosimilar drug development

Managing combination immunotherapy trials from a contract research organization's (CRO's) perspective

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases long term follow-up of two randomized, placebo-controlled trials

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial

Adult participation in oncology clinical trials by indication, race, and age

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events

Highlighting the challenge of delayed overall survival (OS) curve separation in immunotherapy clinical trials

HER2+ gastric cancer patient demographics and implications for clinical trial enrollment

Uptake of BRAF and ALK mutation screening versus HER2 overexpression testing

Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases

Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories

Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade

Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Antecolic Versus Retrocolic Route of the Gastroenteric Anastomosis After Pancreatoduodenectomy: A Randomized Controlled Trial

Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial

RELEASE-HF study: a protocol for an observational, registry-based study on the effectiveness of telemedicine in heart failure in the Netherlands

Aktive Filter

Suchergebnisse filtern